Latest Streaming News

Emyria Limited is fast-tracking its national rollout of Empax mental health clinics, backed by a strong $8 million institutional placement and new dual-payer funding pathways.

HITIQ Limited has launched its PROTEQT™ concussion management system in North America, securing exclusive Canadian distribution rights and initiating a dual-channel market strategy targeting hockey’s vast ecosystem.

Acorn Capital Investment Fund Limited (ACQ) reported a strong FY25 performance with a 15.1% net return and declared 5.5 cents per share in dividends, reinforcing its position in the Australian microcap sector.

Tinybeans Group launches a partially underwritten entitlement offer to fund the integration of its recent acquisition Qeepsake, aiming to boost product innovation and subscriber growth.

LaserBond’s 2025 AGM reveals a pivotal CEO transition alongside a strong financial rebound driven by strategic investments and technology licensing deals.

Growthpoint Properties Australia reported a robust FY25 with funds from operations exceeding guidance, expanded funds management assets, and achieved its Net Zero emissions target ahead of schedule. The company reaffirmed positive FY26 outlook amid leadership changes and ongoing sustainability commitments.

Stakk Limited has secured a strategic multi-year partnership with Stride Bank, a 110-year-old U.S. institution, further accelerating its annualised recurring revenue and broadening its footprint across American financial sectors.

Worley Limited reported solid financial results for FY2025, highlighted by disciplined capital management including a $269 million share buy-back and a strong focus on sustainability. The company outlined strategic priorities and anticipates moderate growth in FY2026 with a new growth strategy to be revealed next year.

AFT Pharmaceuticals reports a robust 33% revenue increase in the first half of FY26, driven by strong ANZ market performance and expanding international presence. The company advances its R&D pipeline and targets NZ$300 million revenue for FY27 amid strategic global expansion.

AFT Pharmaceuticals delivered a robust first half for FY26, posting 33% revenue growth and a return to profitability, driven by strong Australian sales and recovery in Asia and international markets. The company is advancing its global footprint and R&D pipeline, positioning for sustained growth.

I Synergy Group’s subsidiary has inked four separate 12-month leases for its AI computing hardware and software, marking a strategic push into recurring revenue streams.

Conrad Asia Energy Ltd has had its trading suspension lifted following the completion of a significant farm down of 75% of its Duyung Production Sharing Contract. This move marks a pivotal moment for the company’s asset portfolio and market presence.